Austedo

Teva is eyeing $2.5bn in Austedo sales in 2027
Pharmaphorum
Fri, 05/19/23 - 10:07 am
Teva Pharmaceutical
Austedo
Teva gains FDA approval for once-daily formulation of flagship drug Austedo
Fierce Pharma
Wed, 02/22/23 - 10:09 am
Teva Pharmaceutical
FDA
Austedo
tardive dyskinesia
Huntington's disease
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Teva Pharmaceutical
Austedo
clinical trials
chorea
Huntington's disease
Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Teva Pharmaceutical
Austedo
generics
patents
tardive dyskinesia
Aurobindo
Teva settlement prevents Lupin from launching its Austedo generic until 2033
Fierce Pharma
Mon, 05/2/22 - 06:34 pm
Teva Pharmaceutical
tardive dyskinesia
Austedo
Lupin
generics
Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals
Fierce Pharma
Thu, 07/22/21 - 10:57 am
Teva Pharmaceutical
Ajovy
Austedo
Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market
Fierce Pharma
Fri, 05/28/21 - 11:14 am
Teva Pharmaceutical
tardive dyskinesia
DTC ads
Austedo
Lagging rival Neurocrine, Teva preps ad campaign in tardive dyskinesia
Fierce Pharma
Thu, 04/29/21 - 10:27 am
Teva Pharmaceutical
tardive dyskinesia
Austedo
DTC ads
Teva forecasts 'tenfold' growth for new launch Austedo. Why don't analysts agree?
Fierce Pharma
Wed, 11/20/19 - 10:26 pm
Teva Pharmaceutical
Austedo
Huntington's disease
tardive dyskinesia
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Fierce Pharma
Mon, 12/18/17 - 11:25 am
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
New Neurocrine, Teva meds win doctors' praise, fueling bigger sales expectations
Fierce Pharma
Wed, 10/11/17 - 11:02 am
Neurocrine
Teva Pharmaceutical
physicians
Ingrezza
Austedo
tardive dyskinesia
Teva takes on Neurocrine with TD nod for Austedo
Fierce Pharma
Thu, 08/31/17 - 09:26 am
Teva Pharmaceutical
Neurocrine
Austedo
tardive dyskinesia
FDA
FDA Determines that Deuterated Compounds are NCEs and Different Orphan Drugs Versus Non-deuterated Versions
FDA Law Blog
Mon, 07/17/17 - 10:00 am
FDA
deuterated drugs
NCEs
Austedo
Teva Pharmaceutical
orphan drugs
In a first for deuterated drugs, FDA (finally) OKs Teva’s would-be Huntington’s blockbuster Austedo
Endpoints
Tue, 04/4/17 - 07:28 pm
FDA
Teva Pharmaceutical
deuterated drugs
Huntington's disease
deutetrabenazine
Austedo